Chennai, August 29, 2024: – Apollo Hospitals to conduct its 5th edition of Apollo International Colorectal Surgery Symposium (AICRS 2024). One of the main highlights of the symposium will be the release of the latest patient clinical outcomes from the coveted Apollo Rectal Cancer (ARC) Programme.
Apollo Hospitals, a pioneer in the field of advanced colorectal healthcare, transforms the landscape of colorectal surgery with the introduction of innovative clinical initiatives. These initiatives are designed to enhance surgical precision, improve patient outcomes, and streamline care processes, thereby, solidifying Apollo’s position as a global leader in colorectal healthcare.
The Apollo Proton Cancer Centre’s ARC Programme has achieved outstanding clinical outcomes in rectal cancer surgery, surpassing global standards in key areas. Notably, the programme has reported a lower resection margin positivity rate of 4.6% compared to the global standard of 5.2%, anastomotic leak rates of 0.9% versus 2.6%, wound infection rates of 1.4% versus 5.2%, and readmission rates of 1.9% versus 21.4%. Additionally, the programme has seen a significant reduction in robotic to open conversion rates, at 1% compared to 7.0%. These exceptional outcomes have also led to improved survival rates, with significant advancements in treatment protocols contributing to higher long-term survival rates for rectal cancer patients.
Prof Venkatesh Munikrishnan, Clinical Lead- Institute of Colorectal Surgery, Apollo Hospitals, said, “The 5th Apollo International Colorectal Surgery Symposium, is a landmark event that is poised to revolutionize colorectal cancer care. We have standardized robotic surgeries and built the world’s most cost-efficient robotic surgery programme for colorectal cancer. On an average, we are at ¼th cost of a similar procedure in western countries. Apollo Proton’s ARC Programme has been a game-changer in rectal cancer treatment, where we’ve seen remarkable outcomes, enhancing patients’ quality of life.”
Prof Steven D Wexner, Director, Digestive Disease Centre & Chairman- Dept of Colorectal Surgery, Cleveland Clinic Florida, USA, said, “The opportunity for the colorectal surgeons among three of the world’s leading departments, in North America, Asia, and Europe is unique. The unparalleled collaboration among doctors Munikrishnan, Chand, and Wexner during the last decade has included sharing best practices, educational enrichment, and technological advancement. All of these improvements have led to continuous optimization of patient outcomes. The willingness of the three surgeons to generously share their knowledge in various forums has helped ensure that their collaborative advances can reach patients around the world.”
Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, said, “The Apollo International Colorectal Surgery Symposium stands as a premier global event, bringing together the world’s most distinguished experts, researchers, and clinicians in colorectal surgery. This ground-breaking symposium is not just a gathering of minds; it is a transformative learning experience, especially for young surgeons. In an unprecedented move in India, we have made registration complimentary, ensuring that emerging talent has unhindered access to this wealth of knowledge. Our ARC Programme has consistently delivered exceptional clinical outcomes, surpassing global benchmarks in several critical areas. We are privileged to showcase these achievements at the 5th Apollo International Colorectal Surgery Symposium, further reinforcing our commitment to advancing healthcare.”
AICRS2024 Event Highlights
The 5th Apollo International Colorectal Surgery Symposium is set to take place from 30th August to 1st September 2024 at the Hyatt Regency, Chennai. The three-day symposium aims to share knowledge and collaborate on the latest advancements in colorectal surgery.
This year’s event features:
#WinningOverCancer
About Apollo Hospitals:
It was in 1983 Dr Prathap C Reddy launched India’s first corporate hospital in Chennai. Apollo hospital is Asia’s foremost trusted integrated healthcare group, with over 12,000 beds spread across 72 hospitals. The Group has over 5,000 pharmacies, 400 Primary care clinics, and 1,228 ddiagnostic centres. It also has a state-of-the art R&D with a strong focus on global clinical trials. The group has invested in over 15 medical education centres with a purpose of grooming the next generation of caregivers.
In 2010, Dr Prathap C Reddy, Chairman of Apollo Hospitals, was conferred with the prestigious Padma Vibhushan award.
The Government of India has issued a commemorative stamp in recognition of Apollo’s contribution to the healthcare sector.
About Apollo Proton Cancer Centre (APCC), Chennai, India:
Apollo Proton Cancer Centre is the most advanced Cancer Centre and the first Proton Therapy Centre in South Asia & the Middle East. It is also India’s first JCI-accredited Cancer hospital. APCC is country’s first hospital to have proton beam therapy in clinical operation. At the bedrock of APCC’s approach to treating cancer is its robust multi-disciplinary platform; highly skilled professionals who come together to form a cancer management team (CMT). Each CMT is focused on delivering the best possible outcomes for its patients. An added feather in the cap is the recent launch of India’s first & only site-specific Robotic Oncology Program.
For media inquiries or further information, please contact: MSL
Jagan R | jagan.rajagopalan@mslgroup.com | 9840966867
Samayeshwari Vithaspa | Samayeshwari.Vithaspa@mslgroup.com | 9940032587
Nanda Gopal | nanda.gopal@mslgroup.com | 9176218089